Predicting bipolar disorder relapse risk with multi-modal sentiment analysis
Official title: An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature Fusion
Run by Shanghai Mental Health Center · NCT07573839 · Data updated 2026-11-12
This project tests whether combining speech, facial, and other emotional signals can help predict relapse risk in adults with bipolar disorder.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | April 2026 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT07573839 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–64 of Han Chinese ethnicity with a DSM-5 diagnosis of bipolar disorder who are clinically stable, able to hear and see adequately, and consenting to study procedures are eligible.
✕Probably not a fit
Patients with intellectual disability, serious or unstable physical or neurological illnesses, those unable to complete assessments, or those outside the specified age range or ethnicity are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will enroll about 200 adults who meet DSM-5 criteria for bipolar disorder and are currently clinically stable. Researchers will collect multi-modal emotional data — such as voice recordings, facial expressions, and other behavioral signals — and fuse these features using sentiment-analysis and machine-learning methods. The goal is to build predictive models of recurrence risk based on these fused emotional features, leveraging prior cognitive neuroimaging and big-data work from the investigators. There is no interventional treatment; participants complete assessments and recordings during scheduled visits at the study site.
Why it matters
Potential benefit: If successful, the work could enable earlier identification of patients at high risk of relapse so clinicians can offer preventative care sooner.
How similar studies have gone: Previous single- and dual-modality emotion-analysis studies have shown some promise in mood monitoring, but multi-modal feature-fusion approaches for predicting bipolar relapse remain relatively novel and not yet widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patients group inclusion criteria: * Patients who have previously met or currently meet the diagnostic criteria for bipolar disorder according to DSM-5, whose condition and treatment are currently stable, and who cooperate with the assessment; * Age ≥18 years, \<65 years; * Han Chinese ethnicity; * Sufficient visual and auditory abilities to complete the necessary examinations for the study; * Understanding the study content and signing the informed consent form. If the patient is unable to sign the informed consent form personally due to low education level or other reasons, it may be signed by a relative or guardian on their behalf. exclusion criteria: * The presence of intellectual disability or other conditions that significantly affect the patient's current mental state; * the patient has a serious or unstable physical illness, including: neurological disorders (delirium, dementia, stroke, epilepsy, migraine, etc.), congestive heart failure, angina pectoris, myocardial infarction, arrhythmia, hypertension (including untreated or uncontrolled hypertension), malignant tumors, immunodeficiency, and blood glucose levels higher than 12 mmol/L; or other diseases that may interfere with the test assessment (abnormal indicators more than twice the normal value). Healthy controls group inclusion criteria: * Age ≥ 18 years, \< 65 years; * Han Chinese ethnicity; * Gender matched to the patient group; * Sufficient visual and auditory ability to complete the necessary examinations for the study; * Understanding of the study content and signing of informed consent; * No family history of mental illness. exclusion criteria: * Individuals with a mental disorder conforming to DSM-5, or those with suspicious mental symptoms but not meeting the diagnostic criteria; * Individuals with severe physical illness that makes it difficult to complete the necessary examinations.
Where it's running
-
Shanghai Mental Health Center
Shanghai, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
-
Environmental factors and Type 1 diabetes risk in China
This observation study tests how environmental factors may influence Type 1 diabetes risk in China, including patients, healthy controls, and relatives.
-
Paired Stimulation to Help Motor Recovery in Adults With and Without Spinal Cord Injury
This study tests whether paired stimulation can boost how nerves control leg movement in adults with spinal cord injury and in healthy controls.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.